Tyra Bioscience Statistics
Want to see TYRA full AI Analyst Report?
Tyra Bioscience (TYRA) Stock Statistics & Valuation Metrics
Total Valuation
Tyra Bioscience has a market cap or net worth of $1.38B. The enterprise value is $815.64M.
- Market Cap
- $1.38B
- Enterprise Value
- $815.64M
Share Statistics
Tyra Bioscience has 69,082,750 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 69,082,750
- Owned by Insiders
- 25.66%
- Owned by Institutions
- 42.51%
Financial Efficiency
Tyra Bioscience’s return on equity (ROE) is -0.46 and return on invested capital (ROIC) is -50.10%.
- Return on Equity (ROE)
- -0.46
- Return on Assets (ROA)
- -0.42
- Return on Invested Capital (ROIC)
- -50.10%
- Return on Capital Employed (ROCE)
- -0.50
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.38M
- Employee Count
- 87
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Tyra Bioscience is -7.59. Tyra Bioscience’s PEG ratio is 0.24.
- PE Ratio
- -7.59
- PS Ratio
- 0.00
- PB Ratio
- 2.00
- Price to FCF
- -11.53
- Price to Operating Cash Flow
- -11.58
- PEG Ratio
- 0.24
Income Statement
In the last 12 months, Tyra Bioscience had revenue of 0 and earned -119.95M in profits. Earnings per share was -2.01.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -132.76M
- Pretax Income
- -119.95M
- Net Income
- -119.95M
- EBITDA
- -119.40M
- Earnings Per Share (EPS)
- -2.01
Cash Flow
In the last 12 months, operating cash flow was -119.48M and capital expenditures -301,000, giving a free cash flow of -119.78M billion.
- Operating Cash Flow
- -119.48M
- Free Cash Flow
- -119.78M
- Free Cash Flow per Share
- -1.73
Dividends & Yields
Tyra Bioscience pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -8.67%
- Earnings Yield
- -12.28%
Stock Price Statistics
- Beta
- 0.90
- 52-Week Price Change
- 28.45%
- 50-Day Moving Average
- 21.75
- 200-Day Moving Average
- 29.43
- Relative Strength Index (RSI)
- 42.73
- Average Volume (3m)
- 841.26K
Important Dates
Tyra Bioscience upcoming earnings date is Mar 24, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 10, 2026
- Next Earnings Date
- Mar 24, 2027
- Ex-Dividend Date
- ―
Financial Position
Tyra Bioscience as a current ratio of 14.67, with Debt / Equity ratio of 2.24%
- Current Ratio
- 14.67
- Quick Ratio
- 14.67
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.60
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Tyra Bioscience has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Tyra Bioscience EV to EBITDA ratio is -5.38, with an EV/FCF ratio of -7.77.
- EV to Sales
- 0.00
- EV to EBITDA
- -5.38
- EV to Free Cash Flow
- -7.77
- EV to Operating Cash Flow
- -7.79
Balance Sheet
Tyra Bioscience has $700.55M in cash and marketable securities with $5.46M in debt, giving a net cash position of $695.08M billion.
- Cash & Marketable Securities
- $700.55M
- Total Debt
- $5.46M
- Net Cash
- $695.08M
- Net Cash Per Share
- $10.06
- Tangible Book Value Per Share
- $10.03
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Tyra Bioscience is $47.78, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $47.78
- Price Target Upside
- 138.59% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 10
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -40.04%
Scores
- Smart Score
- 6
- AI Score
- 55

